Wake County commissioners approve amended WakeMed transfer deal with Atrium after weeks of public testimony

The Wake County Board of Commissioners voted 5'to' 2 on Sept. 21 to approve amendments to WakeMed's articles of incorporation and the county's 1997 transfer agreement that permit Atrium Health to become a sole member of WakeMed in a negotiated combination.

The vote authorizes the chair to execute the documents conditioned on specific terms satisfactory to the county attorney, including language that Atrium will provide the $2 billion capital commitment from Atrium sources over a 15-year period and incorporation of the 9/19/2026 letter that caps annual reimbursement increases at 1.5 times the annual Medicare increase for five years. Commissioner Thomas moved the measure; Commissioner Jackson seconded it and the motion passed by roll call (five yes, two no).

The decision came after a lengthy public comment period in which hundreds of residents, clinicians, WakeMed employees and community advocates urged the board either to block the deal or to insist on enforceable protections. Opponents warned that national evidence shows hospital consolidation often leads to higher prices and poorer staffing ratios; supporters, including some WakeMed board members and Atrium employees, urged approval to secure major capital projects and long-term stability.

County attorneys summarized the negotiated legal protections that shaped the vote. Those include an increased indigent-care floor raised from 4.8% to a minimum 8% of adjusted revenue, a new $150 million Wake County Whole Health Program to be paid as $15 million annually over 10 years, a covenant limiting extraordinary debt-collection practices, reporting and audit requirements, and a preserved reversionary interest in county real estate that can trigger remedies if WakeMed ceases to meet statutory public-purpose requirements. Attorneys also described enforcement pathways for local community directors to compel mediation or binding arbitration if Atrium fails to meet contractual obligations.

Commissioners framed their votes differently. Supporters said the amended deal strengthens WakeMed's finances, guarantees enforceable community benefits and preserves core safeguards; they emphasized the capital projects named by WakeMed leadership and the administration's insistence that Atrium fund $2 billion from Atrium sources. Dissenting commissioners and many public speakers said the timing and scope of the process left unanswered questions about oversight, transparency and long-term price impacts.

The board's approval does not close the transaction. County attorneys said federal antitrust reviews by the Federal Trade Commission and Department of Justice and final, enforceable member-addition language remain necessary steps before the agreement can be executed.